首頁 > 市場調查報告書 > 醫療設備

藥物遞輸設備

市場調查報告書

商品編碼

1853461

家庭輸液服務市場按交付方式、最終用戶、給藥途徑、服務類型和治療類型分類－2025-2032年全球預測

Home Infusion Services Market by Delivery Mode, End User, Route Of Administration, Service Type, Therapy Type - Global Forecast 2025-2032

出版日期: 2025年09月30日 | 出版商:

360iResearch | 英文 191 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄圖表

預計到 2032 年，家庭輸液服務市場規模將達到 524.9 億美元，複合年成長率為 10.12%。

主要市場統計數據
基準年 2024	242.6億美元
預計年份：2025年	267.2億美元
預測年份：2032年	524.9億美元
複合年成長率 (%)	10.12%

本文簡要概述了臨床進展、實踐創新和支付方動態如何重塑整個護理過程中的家庭輸液服務。

隨著臨床複雜性的增加，居家輸液服務正迅速發展，越來越多的患者需要從傳統的住院轉向居家治療。輸液療法的進步，加上輸液設備便攜性的提高和報銷管道的拓展，使得門診和家庭靜脈及皮下輸液治療日益成為綜合患者照護的重要組成部分。醫療服務提供者正在積極調整其照護模式，在確保安全性、連續性和成本效益的同時，維持與機構照護相當的臨床績效標準。

因此，臨床、營運和支付方等各相關人員正在重新評估輸液服務的委託和交付方式。臨床醫生正在整合遠端監測和遠端醫療，以支援護理和藥物管理工作流程；同時，管理人員正在與專科藥房和配藥機構建立夥伴關係，以確保無菌產品的供應。因此，決策者在設計可擴展的家庭輸液項目時，必須同時考慮臨床能力、供應鏈的穩健性和監管合規性。

數位醫療、小型輸液技術和監管調整將如何推動輸液護理模式模式轉移

隨著技術創新、監管調整和患者偏好的融合，輸液治療服務模式正在改變。居家醫療不再是小眾選擇，而是逐漸成為策略性整合方案，旨在減少住院次數並改善病患體驗。小型門診輸液幫浦和皮下給藥技術的應用，以及病患教育和遠距臨床監測的改進，正在拓展可在院外安全實施的治療方法範圍。

同時，法律規範也在進行調整，以支持分散式醫療模式，強調品質指標、安全配藥規範和臨床記錄互通性。這種轉變正在推動醫院、門診診所和居家醫療機構之間的整合，從而獎勵那些優先考慮醫療連續性和降低再入院風險的醫療管道。因此，醫療領導者正在投資於人才培養、數位監測和流程標準化，以落實這項轉型並確保患者獲得一致的治療效果。

美國不斷變化的關稅措施對家庭輸液服務提供者和臨床項目的設備和耗材供應鏈的累積營運影響。

2025年的關稅調整正在對輸液護理供應鏈產生波動，影響輸液幫浦、耗材和無菌配製材料的採購。進口醫療設備和原料關稅的提高，增加了傳統上依賴全球化生產佈局的醫療機構和供應商的採購複雜性。因此，採購團隊正在重新評估其供應商組合和合約結構，以降低關稅相關的成本差異和交貨延誤風險。

為此，各公司正優先考慮供應商多元化、關鍵零件近岸採購以及策略性庫存緩衝，以維持臨床服務的連續性。臨床負責人正與採購和藥房相關人員合作，檢驗替代設備方案，並確保其與既定的臨床方案相容。這些調整正在加速企業對國內製造夥伴關係關係和集中採購策略的興趣，這些策略旨在減少交易摩擦，並為輸液服務提供可預測的供應。

關鍵細分洞察揭示了交付模式、最終用戶環境、管理途徑、服務類型和治療類型如何影響營運和臨床策略。

細分分析揭示了不同給藥方式、最終用戶、給藥途徑、服務類型和治療類別在運作和臨床方面的差異。給藥方式（靜脈注射與皮下注射）的差異會影響給藥裝置的選擇、護理師的資格以及監測強度，靜脈注射通常需要更密切的監測，而皮下注射則更適合門診病人給藥。診所、居家醫療機構和醫院的最終用戶各不相同，因此需要協調不同的人員配備模式、資格認證程序和物流網路，以促進有效的護理交接。

給藥途徑分為中心途徑和周邊途徑，影響血管通路管理、感染預防通訊協定和病患教育的重點。服務類型包括藥房服務、護理服務和病患監測，形成一個整合的服務架構，其中無菌製劑的品質直接影響護理工作流程效率和遠距監護系統。例如，抗生素輸注使用具有不同藥物動力學和安全性特徵的藥物，如Aminoglycosides、BETA-內醯胺類和Fluoroquinolones。腫瘤治療區分靜脈注射都需要獨特的輸注方案和毒性管理。疼痛管理分為非鴉片類藥物輸注和鴉片類藥物輸注，每種輸注方式都需要不同的法律規範和監測方案。腸外營養分為周邊腸外營養和全腸外營養，每種腸外營養都需要不同的代謝監測和導管注意事項。

綜上所述，這些細分因素指導醫療服務提供者如何設計臨床通訊協定、分配設備和配藥能力所需的資金，以及如何配置符合支付方要求和以患者為中心的治療方案。因此，相關人員必須使其營運模式和品質保證機制與交付模式、最終用戶環境、給藥途徑、服務類型和治療特徵等因素的交匯點相匹配，以確保安全、高效且以患者為中心的輸液治療。

亞太、歐洲、中東和非洲地區的區域機會和限制將決定採用通路和營運規模。

區域動態正在再形成美洲、歐洲、中東和非洲以及亞太地區家庭輸液服務的普及和擴展。在美洲，門診病人報銷框架和與現有居家醫療基礎設施相協調的監管政策正在推動輸液服務的快速普及，而人口老齡化和慢性病患病率的上升則持續推高了對門診護理的需求。同時，在歐洲、中東和非洲，由於報銷體系和醫療服務結構的差異，情況呈現出明顯的多樣性。一些國家優先發展集中式醫院服務，而另一些國家則在試行由遠端醫療和社區護理網路支援的分散式輸液服務。

在亞太地區，國內醫療器材製造業的快速發展、私人醫療機構的擴張以及對數位醫療平台投資的不斷成長，使得居家輸液護理得以廣泛普及，但監管標準和勞動力的差異可能會限制其統一推廣。供應鏈彈性、器材核准時間以及區域配藥能力等方面的差異，都會影響居家輸液模式整合的速度與規模。因此，為了成功營運居家輸液項目，區域策略必須考慮支付方結構、勞動力準備以及監管協調性。

策略夥伴關係、對認證的重視以及數位化賦能如何塑造輸液生態系統中各公司的競爭差異化與能力發展

家庭輸液生態系統的企業級動態以策略聯盟、差異化能力以及對臨床和供應鏈能力的定向投資為特徵。醫療服務提供者正與專科藥房、設備製造商和技術供應商合作，創建整合式護理路徑，以減少交接環節並提高護理的連續性。同時，擁有強大數位監測平台的參與企業正透過提供以分析主導的依從性和安全性監測，為護理服務提供補充，從而獲得市場認可。

競爭優勢通常體現在服務範圍、嚴格的合規性以及提供複雜治療方法並確保臨床療效一致性的能力。行業領導者優先考慮認證、標準化配藥流程和嚴格的培訓項目，以支持更先進的居家輸液治療。此外，投資於與電子健康記錄和遠端醫療平台互通性的公司能夠加強護理協調並減少行政管理方面的摩擦。總之，能夠將卓越的臨床水平、強大的供應鏈韌性和數位化應對力相結合，從而支持各種治療類型和護理環境的機構，在競爭環境中更具優勢。

為領導者提供切實可行的營運和策略建議，以確保家庭輸液服務的供應彈性、臨床能力和報銷完整性

產業領導者應採取一系列切實可行的措施，充分利用分散式輸液帶來的機遇，同時保障臨床標準和營運連續性。此外，他們還應實施庫存管治框架，在不造成不必要資金負擔的前提下，維持臨床用藥的可近性。其次，對人才隊伍建立的投入至關重要。臨床醫生和藥房工作人員需要接受標準化的能力培訓，內容涵蓋血管通路管理、輸液裝置操作和遠端分流通訊協定。

此外，將遠端監測和遠端醫療整合到核心服務管道中應是優先事項，以支持患者儘早出院並降低再入院風險。將臨床、藥房和管治職能部門聯繫起來的跨職能管理正在加速新治療方法和新設備的引入，同時確保符合監管要求。最後，支付方和醫療服務提供者應認知到居家輸液在以患者為中心的護理中的價值，並合作制定報銷模式，以獎勵基於結果的合約和風險分擔安排，從而獎勵高品質和連續性的護理。

透過透明的混合方法，結合相關人員訪談、監管整合和交叉檢驗，深入了解輸液計畫的運作。

本報告的調查方法結合了質性訪談、文獻綜述和檢驗，以確保研究結果的可靠性和可操作性。主要資訊是透過對臨床醫生、藥房負責人、採購主管和家庭醫療保健經理進行結構化訪談收集的，旨在了解第一線營運挑戰和策略重點。此外，還系統地審查了監管指南、設備規格和專業標準，以確保臨床建議符合普遍的安全和品質預期。

分析過程包括將訪談主題與觀察到的行業舉措和公共變化進行交叉檢驗，從而在不依賴單一資料來源的情況下識別出新興模式。在整個過程中，我們始終專注於資料來源並努力減少潛在偏差，確保結果能夠平衡地反映相關人員的觀點和已記錄的實踐。這種混合方法的調查方法使我們能夠提出切實可行的建議，並深入了解影響家庭輸液服務成功部署的各項營運因素。

前瞻性概述重點介紹了臨床卓越性、供應鏈韌性和數位化監控的整合，以實現永續的居家輸液護理。

隨著臨床能力、數位化監測和病患偏好的日益融合，居家輸液服務將在現代醫療服務中發揮越來越重要的作用。醫療保健的成功取決於將無菌產品品質、護理能力和供應鏈韌性整合到一個連貫的方案中，以滿足支付方的期望和監管標準。隨著相關人員採用分散式輸液管道，對互通性、臨床醫生培訓和病人安全的關注將決定哪些模式能夠有效且永續地擴展。

未來，隨著設備小型化、皮下治療方案的拓展以及遠端監測機制的出現，適合居家治療的療法範圍可望進一步擴大。然而，營運上的謹慎，包括多元化的資源取得、嚴格的認證以及以療效為導向的合約簽訂，對於將臨床潛力轉化為可靠的、以患者為中心的醫療服務仍然至關重要。

整合遠端醫療平台，用於輸液治療期間的即時遠端監測和患者支持
採用人工智慧驅動的給藥演算法，以最佳化輸液治療的準確性和安全性
擴大報銷範圍，涵蓋專業的居家輸液服務，並降低病患的自付費用。
利用行動病患監測應用程式和連網輸液設備開發個人化依從性方案
對複雜的生技藥品和腫瘤輸液的需求日益成長，這些都需要專門的居家照護基礎設施和培訓。
透過家庭輸液服務提供者和專科藥房之間的策略夥伴關係，實現端到端的連續性護理
實施穿戴式安全感測器和物聯網系統，以加強家庭輸液風險管理和合規性
隨著全國性醫療服務提供者透過併購擴大其本地家庭輸液網路和能力，市場整合正在加劇。

第6章美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 依交付方式分類的家庭輸液服務市場

靜脈
皮下

9. 按最終用戶分類的家庭輸液服務市場

診所
家庭醫療保健機構
醫院

10. 依管理途徑分類的家庭輸液服務市場

中央靜脈
周邊靜脈

第11章：按服務類型分類的家庭輸液服務市場

複合服務
護理服務
病患監測

12. 依治療類型分類的家庭輸液服務市場

靜脈注射抗生素
- Aminoglycosides
- BETA-內醯胺類
- Fluoroquinolones
腫瘤學
- 靜脈腫瘤治療
- 皮下腫瘤治療
疼痛管理
- 非鴉片類藥物輸注
- 鴉片類藥物輸注
靜脈營養
- 周邊靜脈營養
- 全靜脈營養

13. 按地區分類的家庭輸液服務市場

美洲
- 北美洲
- 拉丁美洲
歐洲、中東和非洲
- 歐洲
- 中東
- 非洲
亞太地區

第14章：依群體分類的家庭輸液服務市場

ASEAN
GCC
EU
BRICS
G7
NATO

15. 各國家庭輸液服務市場

美國
加拿大
墨西哥
巴西
英國
德國
法國
俄羅斯
義大利
西班牙
中國
印度
日本
澳洲
韓國

第16章競爭格局

2024年市佔率分析
FPNV定位矩陣，2024
競爭分析
- Option Care Health, Inc.
- CVS Health Corporation
- InfuSystem Holdings, Inc.
- Baxter International Inc.
- B. Braun Melsungen AG
- Fresenius Kabi AG
- Becton, Dickinson and Company
- ICU Medical, Inc.
- Terumo Corporation
- Nipro Corporation

簡介目錄圖表

Product Code: MRR-3A2E844FEC05

The Home Infusion Services Market is projected to grow by USD 52.49 billion at a CAGR of 10.12% by 2032.

KEY MARKET STATISTICS
Base Year [2024]	USD 24.26 billion
Estimated Year [2025]	USD 26.72 billion
Forecast Year [2032]	USD 52.49 billion
CAGR (%)	10.12%

A concise orientation to how clinical advances, operational innovations, and payer dynamics are reshaping home infusion delivery across care continuums

The home infusion services landscape is evolving rapidly as clinical complexity shifts care beyond traditional inpatient settings and into patients' homes. Advances in infusion therapeutics, combined with enhanced portability of infusion devices and expanded reimbursement pathways, have made outpatient and home-based intravenous and subcutaneous therapies an increasingly viable component of comprehensive patient care. Providers are responding by reconfiguring care models to prioritize safety, continuity, and cost efficiency while maintaining clinical performance standards comparable to facility-based care.

As a result, stakeholders across clinical, operational, and payer communities are reassessing how infusion services are commissioned and delivered. Clinicians are integrating remote monitoring and telehealth to support nursing and medication administration workflows, whereas administrators are building partnerships with specialty pharmacies and compounding facilities to secure sterile preparations. Consequently, decision-makers must consider clinical competency, supply chain robustness, and regulatory compliance in parallel when designing scalable home infusion programs.

How digital health, compact infusion technologies, and regulatory adaptations collectively drive a paradigm shift toward decentralized infusion care

Care delivery for infusion therapies is undergoing transformative shifts as technological innovation, regulatory adjustments, and patient preferences converge. Home-based care is no longer a niche alternative; it is being embedded as a strategic option to reduce inpatient utilization and to improve patient experience. The adoption of compact ambulatory infusion pumps and subcutaneous administration techniques, alongside improvements in patient education and remote clinical oversight, has expanded the range of therapies that can be safely managed outside the hospital.

Meanwhile, regulatory frameworks are adapting to support decentralized care models, emphasizing quality metrics, safe compounding practices, and interoperability of clinical records. These shifts encourage integration between hospitals, outpatient clinics, and home healthcare entities and create incentives for care pathways that prioritize continuity and reduced readmission risk. In turn, healthcare leaders are investing in workforce training, digital monitoring, and process standardization to operationalize these transformative changes and to ensure consistent patient outcomes.

The cumulative operational consequences of evolving U.S. tariff policy on device and consumable supply chains for home infusion providers and clinical programs

Tariff policy adjustments in 2025 are creating ripples across supply chains that support infusion care, affecting procurement of infusion pumps, disposables, and sterile compounding inputs. Increased duties on imported medical devices and raw materials have raised sourcing complexity for providers and suppliers that historically relied on globalized manufacturing footprints. Consequently, procurement teams are reassessing vendor portfolios and contract structures to mitigate exposure to customs-related cost volatility and delivery delays.

In response, organizations are prioritizing supplier diversification, nearshoring of critical components, and strategic inventory buffering to maintain clinical continuity. Clinical leaders are collaborating with procurement and pharmacy stakeholders to validate alternative device options and to ensure compatibility with established clinical protocols. Over time, these adjustments are accelerating interest in domestic manufacturing partnerships and aggregated purchasing strategies that reduce transactional friction and support predictable supply flows for infusion services.

Critical segmentation insights that demonstrate how delivery mode, end user environment, administration route, service type, and therapy type jointly shape operational and clinical strategies

Segmentation analysis reveals differentiated operational and clinical considerations across delivery modes, end users, administration routes, service types, and therapy categories. Delivery mode distinctions between intravenous and subcutaneous pathways inform device selection, nursing competencies, and monitoring intensity, with intravenous therapies often requiring higher acuity oversight and subcutaneous options enabling broader outpatient administration. End user variation across clinics, home healthcare agencies, and hospitals translates to divergent staffing models, credentialing procedures, and logistical networks that must be coordinated for effective transitions of care.

Route of administration divides into central and peripheral approaches, shaping vascular access management, infection prevention protocols, and patient education priorities. Service types encompassing compounding services, nursing services, and patient monitoring form an integrated service architecture where sterile preparation quality feeds directly into nursing workflow efficiency and remote monitoring systems. Therapy-type groupings-antibiotic infusion, oncology, pain management, and parenteral nutrition-require therapy-specific clinical pathways; for example, antibiotic infusion spans aminoglycosides, beta-lactams, and fluoroquinolones with distinct pharmacokinetic and safety profiles, while oncology care differentiates between intravenous oncology agents and subcutaneous oncology agents, each presenting unique infusion scheduling and toxicity management needs. Pain management segregates into non-opioid and opioid infusion strategies, which necessitate different regulatory oversight and monitoring protocols, and parenteral nutrition splits into peripheral parenteral nutrition and total parenteral nutrition, each with distinct metabolic monitoring and catheter considerations.

Taken together, these segmentation dimensions inform how providers design clinical protocols, allocate capital for devices and compounding capacity, and structure care bundles that align with payer requirements and patient-centered outcomes. Consequently, stakeholders must tailor operational models and quality assurance mechanisms to the specific intersection of delivery mode, end user environment, administration route, service type, and therapy characteristics to ensure safe, efficient, and patient-focused infusion care.

Regional opportunities and constraints across the Americas, Europe Middle East & Africa, and Asia-Pacific that determine adoption pathways and operational scalability

Regional dynamics are reshaping how home infusion services are implemented and scaled, with distinct drivers and constraints across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, regulatory alignment with outpatient reimbursement frameworks and established home health infrastructures supports rapid uptake of infusion services, while population aging and chronic disease prevalence create sustained demand for ambulatory therapy delivery. Meanwhile, Europe, Middle East & Africa displays heterogeneity driven by divergent reimbursement regimes and healthcare delivery structures; some national systems prioritize centralized hospital services while others are piloting decentralized infusion pathways supported by telehealth and community nursing networks.

In Asia-Pacific, rapid development of domestic medical manufacturing, expansion of private healthcare providers, and growing investments in digital health platforms are enabling broader access to home-based infusion care, although variability in regulatory standards and workforce capacity can constrain uniform deployment. Across regions, differences in supply chain resilience, device approval timelines, and local compounding capabilities influence the speed and scale at which home infusion models can be integrated. Therefore, regional strategy must account for payer structures, workforce readiness, and regulatory alignment to successfully operationalize home infusion programs.

How strategic partnerships, accreditation focus, and digital enablement are shaping competitive differentiation and capability development among firms in the infusion ecosystem

Company-level dynamics in the home infusion ecosystem are characterized by strategic collaborations, capability differentiation, and targeted investments in clinical and supply chain capabilities. Providers are forming alliances with specialty compounding pharmacies, device manufacturers, and technology vendors to build integrated care pathways that reduce handoffs and improve continuity. At the same time, entrants with strong digital monitoring platforms are gaining traction by offering analytics-driven adherence and safety oversight that complement nursing services.

Competitive differentiation often centers on service breadth, compliance rigor, and the ability to deliver complex therapies with consistent clinical outcomes. Leaders prioritize accreditation, standardized compounding processes, and rigorous training programs to support higher-acuity home infusions. Additionally, firms that invest in interoperability with electronic health records and telehealth platforms enhance care coordination and reduce administrative friction. In sum, the corporate landscape favors organizations that can combine clinical excellence, supply chain resilience, and digital enablement to support a wide range of therapy types and care settings.

Actionable operational and strategic recommendations for leaders to secure supply resilience, clinical competency, and reimbursement alignment in home infusion services

Industry leaders should adopt a set of pragmatic actions to capitalize on decentralized infusion opportunities while safeguarding clinical standards and operational continuity. First, leaders must institutionalize supplier diversification and nearshore sourcing strategies to mitigate tariff-driven supply disruptions; simultaneously, they should implement inventory governance frameworks that preserve clinical access without creating unnecessary capital burden. Second, investment in workforce development is essential: clinicians and pharmacy staff require standardized competency programs that address vascular access management, infusion device operation, and remote triage protocols.

Moreover, organizations should prioritize integration of remote monitoring and telehealth into core service pathways to support earlier discharge and reduce readmission risk. Cross-functional governance that aligns clinical, pharmacy, and procurement functions will accelerate adoption of new therapies and devices while ensuring regulatory compliance. Finally, payers and providers should collaborate on reimbursement models that recognize the value of home infusion in patient-centered care, incentivizing outcomes-focused contracting and shared risk arrangements that reward quality and continuity of care.

Transparent mixed-methods approach combining stakeholder interviews, regulatory synthesis, and cross-validation to produce reliable operational insights for infusion programs

The research methodology underpinning this report integrates primary qualitative interviews, secondary document synthesis, and triangulated validation to ensure robust, actionable findings. Primary inputs were gathered through structured interviews with clinicians, pharmacy leaders, procurement executives, and home healthcare administrators to capture frontline operational challenges and strategic priorities. These insights were supplemented by a systematic review of regulatory guidance, device specifications, and professional standards to ensure clinical recommendations align with prevailing safety and quality expectations.

Analytical processes included cross-validation of interview themes with observed industry initiatives and public policy shifts, enabling identification of emergent patterns without relying on singular data sources. Throughout the process, careful attention was given to data provenance and potential bias mitigation, ensuring that findings reflect a balanced synthesis of stakeholder perspectives and documented practice. This blended methodology supports practical recommendations and a nuanced understanding of operational levers that influence successful deployment of home infusion services.

A forward-looking summary emphasizing integration of clinical excellence, supply chain resilience, and digital monitoring to operationalize sustainable home infusion care

Home infusion services are positioned to play an increasingly central role in modern care delivery as clinical capabilities, digital monitoring, and patient preferences continue to align. Success will depend on the ability of healthcare organizations to integrate sterile compounding quality, nursing competency, and supply chain resilience into coherent programs that meet payer expectations and regulatory standards. As stakeholders adopt decentralized infusion pathways, emphasis on interoperability, clinician training, and patient safety will determine which models scale effectively and sustainably.

Looking ahead, the convergence of device miniaturization, expanded subcutaneous therapy options, and remote oversight mechanisms will broaden the therapeutic scope suitable for home administration. Nevertheless, operational prudence-manifested as diversified sourcing, rigorous accreditation, and outcome-focused contracting-will remain essential to translating clinical potential into reliable, patient-centered care delivery.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Integration of telehealth platforms for real-time remote monitoring and patient support during infusion therapy
5.2. Adoption of artificial intelligence driven dosing algorithms to optimize infusion therapy accuracy and safety
5.3. Expansion of reimbursement policies to cover specialized home infusion services and reduce patient out of pocket costs
5.4. Development of personalized adherence programs leveraging mobile apps and connected infusion devices for patient monitoring
5.5. Rising demand for complex biologics and oncology infusions requiring specialized home care infrastructure and training
5.6. Strategic partnerships between home infusion providers and specialty pharmacies for end to end therapeutic continuity
5.7. Implementation of wearable safety sensors and IoT systems to enhance at home infusion risk management and compliance
5.8. Market consolidation through mergers and acquisitions as national providers expand regional home infusion networks and capabilities

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Home Infusion Services Market, by Delivery Mode

8.1. Intravenous
8.2. Subcutaneous

9. Home Infusion Services Market, by End User

9.1. Clinics
9.2. Home Healthcare Agencies
9.3. Hospitals

10. Home Infusion Services Market, by Route Of Administration

10.1. Central
10.2. Peripheral

11. Home Infusion Services Market, by Service Type

11.1. Compounding Services
11.2. Nursing Services
11.3. Patient Monitoring

12. Home Infusion Services Market, by Therapy Type

12.1. Antibiotic Infusion
- 12.1.1. Aminoglycosides
- 12.1.2. Beta Lactams
- 12.1.3. Fluoroquinolones
12.2. Oncology
- 12.2.1. Intravenous Oncology Agents
- 12.2.2. Subcutaneous Oncology Agents
12.3. Pain Management
- 12.3.1. Non Opioid Infusion
- 12.3.2. Opioid Infusion
12.4. Parenteral Nutrition
- 12.4.1. Peripheral Parenteral Nutrition
- 12.4.2. Total Parenteral Nutrition

13. Home Infusion Services Market, by Region

13.1. Americas
- 13.1.1. North America
- 13.1.2. Latin America
13.2. Europe, Middle East & Africa
- 13.2.1. Europe
- 13.2.2. Middle East
- 13.2.3. Africa
13.3. Asia-Pacific

14. Home Infusion Services Market, by Group

14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO

15. Home Infusion Services Market, by Country

15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea

16. Competitive Landscape

16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
- 16.3.1. Option Care Health, Inc.
- 16.3.2. CVS Health Corporation
- 16.3.3. InfuSystem Holdings, Inc.
- 16.3.4. Baxter International Inc.
- 16.3.5. B. Braun Melsungen AG
- 16.3.6. Fresenius Kabi AG
- 16.3.7. Becton, Dickinson and Company
- 16.3.8. ICU Medical, Inc.
- 16.3.9. Terumo Corporation
- 16.3.10. Nipro Corporation

簡介目錄圖表

LIST OF FIGURES

FIGURE 1. GLOBAL HOME INFUSION SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2024 VS 2032 (%)
FIGURE 3. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2024 VS 2025 VS 2032 (USD MILLION)
FIGURE 4. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
FIGURE 5. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2032 (%)
FIGURE 7. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2024 VS 2032 (%)
FIGURE 9. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2024 VS 2032 (%)
FIGURE 11. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
FIGURE 13. AMERICAS HOME INFUSION SERVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
FIGURE 14. NORTH AMERICA HOME INFUSION SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
FIGURE 15. LATIN AMERICA HOME INFUSION SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
FIGURE 16. EUROPE, MIDDLE EAST & AFRICA HOME INFUSION SERVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
FIGURE 17. EUROPE HOME INFUSION SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
FIGURE 18. MIDDLE EAST HOME INFUSION SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
FIGURE 19. AFRICA HOME INFUSION SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
FIGURE 20. ASIA-PACIFIC HOME INFUSION SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
FIGURE 21. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
FIGURE 22. ASEAN HOME INFUSION SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
FIGURE 23. GCC HOME INFUSION SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
FIGURE 24. EUROPEAN UNION HOME INFUSION SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
FIGURE 25. BRICS HOME INFUSION SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
FIGURE 26. G7 HOME INFUSION SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
FIGURE 27. NATO HOME INFUSION SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
FIGURE 28. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
FIGURE 29. HOME INFUSION SERVICES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 30. HOME INFUSION SERVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

TABLE 1. HOME INFUSION SERVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL HOME INFUSION SERVICES MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL HOME INFUSION SERVICES MARKET SIZE, 2025-2032 (USD MILLION)
TABLE 5. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2025-2032 (USD MILLION)
TABLE 7. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2032 (USD MILLION)
TABLE 9. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY INTRAVENOUS, BY GROUP, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY INTRAVENOUS, BY GROUP, 2025-2032 (USD MILLION)
TABLE 11. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY INTRAVENOUS, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY INTRAVENOUS, BY COUNTRY, 2025-2032 (USD MILLION)
TABLE 13. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2025-2032 (USD MILLION)
TABLE 15. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY SUBCUTANEOUS, BY GROUP, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY SUBCUTANEOUS, BY GROUP, 2025-2032 (USD MILLION)
TABLE 17. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY SUBCUTANEOUS, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY SUBCUTANEOUS, BY COUNTRY, 2025-2032 (USD MILLION)
TABLE 19. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
TABLE 21. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY CLINICS, BY REGION, 2025-2032 (USD MILLION)
TABLE 23. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
TABLE 25. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
TABLE 27. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY HOME HEALTHCARE AGENCIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY HOME HEALTHCARE AGENCIES, BY REGION, 2025-2032 (USD MILLION)
TABLE 29. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY HOME HEALTHCARE AGENCIES, BY GROUP, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY HOME HEALTHCARE AGENCIES, BY GROUP, 2025-2032 (USD MILLION)
TABLE 31. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY HOME HEALTHCARE AGENCIES, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY HOME HEALTHCARE AGENCIES, BY COUNTRY, 2025-2032 (USD MILLION)
TABLE 33. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
TABLE 35. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
TABLE 37. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
TABLE 39. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
TABLE 41. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY CENTRAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY CENTRAL, BY REGION, 2025-2032 (USD MILLION)
TABLE 43. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY CENTRAL, BY GROUP, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY CENTRAL, BY GROUP, 2025-2032 (USD MILLION)
TABLE 45. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY CENTRAL, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY CENTRAL, BY COUNTRY, 2025-2032 (USD MILLION)
TABLE 47. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PERIPHERAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PERIPHERAL, BY REGION, 2025-2032 (USD MILLION)
TABLE 49. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PERIPHERAL, BY GROUP, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PERIPHERAL, BY GROUP, 2025-2032 (USD MILLION)
TABLE 51. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PERIPHERAL, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PERIPHERAL, BY COUNTRY, 2025-2032 (USD MILLION)
TABLE 53. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
TABLE 55. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY COMPOUNDING SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY COMPOUNDING SERVICES, BY REGION, 2025-2032 (USD MILLION)
TABLE 57. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY COMPOUNDING SERVICES, BY GROUP, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY COMPOUNDING SERVICES, BY GROUP, 2025-2032 (USD MILLION)
TABLE 59. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY COMPOUNDING SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY COMPOUNDING SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
TABLE 61. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY NURSING SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY NURSING SERVICES, BY REGION, 2025-2032 (USD MILLION)
TABLE 63. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY NURSING SERVICES, BY GROUP, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY NURSING SERVICES, BY GROUP, 2025-2032 (USD MILLION)
TABLE 65. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY NURSING SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY NURSING SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
TABLE 67. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PATIENT MONITORING, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PATIENT MONITORING, BY REGION, 2025-2032 (USD MILLION)
TABLE 69. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PATIENT MONITORING, BY GROUP, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PATIENT MONITORING, BY GROUP, 2025-2032 (USD MILLION)
TABLE 71. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PATIENT MONITORING, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PATIENT MONITORING, BY COUNTRY, 2025-2032 (USD MILLION)
TABLE 73. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2025-2032 (USD MILLION)
TABLE 75. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, 2025-2032 (USD MILLION)
TABLE 77. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, BY REGION, 2025-2032 (USD MILLION)
TABLE 79. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, BY GROUP, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, BY GROUP, 2025-2032 (USD MILLION)
TABLE 81. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, BY COUNTRY, 2025-2032 (USD MILLION)
TABLE 83. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY AMINOGLYCOSIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY AMINOGLYCOSIDES, BY REGION, 2025-2032 (USD MILLION)
TABLE 85. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY AMINOGLYCOSIDES, BY GROUP, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY AMINOGLYCOSIDES, BY GROUP, 2025-2032 (USD MILLION)
TABLE 87. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY AMINOGLYCOSIDES, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY AMINOGLYCOSIDES, BY COUNTRY, 2025-2032 (USD MILLION)
TABLE 89. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY BETA LACTAMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY BETA LACTAMS, BY REGION, 2025-2032 (USD MILLION)
TABLE 91. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY BETA LACTAMS, BY GROUP, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY BETA LACTAMS, BY GROUP, 2025-2032 (USD MILLION)
TABLE 93. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY BETA LACTAMS, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY BETA LACTAMS, BY COUNTRY, 2025-2032 (USD MILLION)
TABLE 95. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY FLUOROQUINOLONES, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY FLUOROQUINOLONES, BY REGION, 2025-2032 (USD MILLION)
TABLE 97. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY FLUOROQUINOLONES, BY GROUP, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY FLUOROQUINOLONES, BY GROUP, 2025-2032 (USD MILLION)
TABLE 99. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY FLUOROQUINOLONES, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY FLUOROQUINOLONES, BY COUNTRY, 2025-2032 (USD MILLION)
TABLE 101. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, 2025-2032 (USD MILLION)
TABLE 103. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2032 (USD MILLION)
TABLE 105. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, BY GROUP, 2025-2032 (USD MILLION)
TABLE 107. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
TABLE 109. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY INTRAVENOUS ONCOLOGY AGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY INTRAVENOUS ONCOLOGY AGENTS, BY REGION, 2025-2032 (USD MILLION)
TABLE 111. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY INTRAVENOUS ONCOLOGY AGENTS, BY GROUP, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY INTRAVENOUS ONCOLOGY AGENTS, BY GROUP, 2025-2032 (USD MILLION)
TABLE 113. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY INTRAVENOUS ONCOLOGY AGENTS, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY INTRAVENOUS ONCOLOGY AGENTS, BY COUNTRY, 2025-2032 (USD MILLION)
TABLE 115. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY SUBCUTANEOUS ONCOLOGY AGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY SUBCUTANEOUS ONCOLOGY AGENTS, BY REGION, 2025-2032 (USD MILLION)
TABLE 117. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY SUBCUTANEOUS ONCOLOGY AGENTS, BY GROUP, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY SUBCUTANEOUS ONCOLOGY AGENTS, BY GROUP, 2025-2032 (USD MILLION)
TABLE 119. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY SUBCUTANEOUS ONCOLOGY AGENTS, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY SUBCUTANEOUS ONCOLOGY AGENTS, BY COUNTRY, 2025-2032 (USD MILLION)
TABLE 121. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PAIN MANAGEMENT, 2025-2032 (USD MILLION)
TABLE 123. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2025-2032 (USD MILLION)
TABLE 125. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PAIN MANAGEMENT, BY GROUP, 2018-2024 (USD MILLION)
TABLE 126. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PAIN MANAGEMENT, BY GROUP, 2025-2032 (USD MILLION)
TABLE 127. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PAIN MANAGEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 128. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PAIN MANAGEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
TABLE 129. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY NON OPIOID INFUSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 130. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY NON OPIOID INFUSION, BY REGION, 2025-2032 (USD MILLION)
TABLE 131. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY NON OPIOID INFUSION, BY GROUP, 2018-2024 (USD MILLION)
TABLE 132. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY NON OPIOID INFUSION, BY GROUP, 2025-2032 (USD MILLION)
TABLE 133. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY NON OPIOID INFUSION, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 134. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY NON OPIOID INFUSION, BY COUNTRY, 2025-2032 (USD MILLION)
TABLE 135. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY OPIOID INFUSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 136. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY OPIOID INFUSION, BY REGION, 2025-2032 (USD MILLION)
TABLE 137. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY OPIOID INFUSION, BY GROUP, 2018-2024 (USD MILLION)
TABLE 138. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY OPIOID INFUSION, BY GROUP, 2025-2032 (USD MILLION)
TABLE 139. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY OPIOID INFUSION, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 140. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY OPIOID INFUSION, BY COUNTRY, 2025-2032 (USD MILLION)
TABLE 141. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2024 (USD MILLION)
TABLE 142. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2025-2032 (USD MILLION)
TABLE 143. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PARENTERAL NUTRITION, BY REGION, 2018-2024 (USD MILLION)
TABLE 144. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PARENTERAL NUTRITION, BY REGION, 2025-2032 (USD MILLION)
TABLE 145. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PARENTERAL NUTRITION, BY GROUP, 2018-2024 (USD MILLION)
TABLE 146. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PARENTERAL NUTRITION, BY GROUP, 2025-2032 (USD MILLION)
TABLE 147. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PARENTERAL NUTRITION, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 148. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PARENTERAL NUTRITION, BY COUNTRY, 2025-2032 (USD MILLION)
TABLE 149. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PERIPHERAL PARENTERAL NUTRITION, BY REGION, 2018-2024 (USD MILLION)
TABLE 150. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PERIPHERAL PARENTERAL NUTRITION, BY REGION, 2025-2032 (USD MILLION)
TABLE 151. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PERIPHERAL PARENTERAL NUTRITION, BY GROUP, 2018-2024 (USD MILLION)
TABLE 152. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PERIPHERAL PARENTERAL NUTRITION, BY GROUP, 2025-2032 (USD MILLION)
TABLE 153. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PERIPHERAL PARENTERAL NUTRITION, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 154. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PERIPHERAL PARENTERAL NUTRITION, BY COUNTRY, 2025-2032 (USD MILLION)
TABLE 155. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY TOTAL PARENTERAL NUTRITION, BY REGION, 2018-2024 (USD MILLION)
TABLE 156. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY TOTAL PARENTERAL NUTRITION, BY REGION, 2025-2032 (USD MILLION)
TABLE 157. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY TOTAL PARENTERAL NUTRITION, BY GROUP, 2018-2024 (USD MILLION)
TABLE 158. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY TOTAL PARENTERAL NUTRITION, BY GROUP, 2025-2032 (USD MILLION)
TABLE 159. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY TOTAL PARENTERAL NUTRITION, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 160. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY TOTAL PARENTERAL NUTRITION, BY COUNTRY, 2025-2032 (USD MILLION)
TABLE 161. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 162. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
TABLE 163. AMERICAS HOME INFUSION SERVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
TABLE 164. AMERICAS HOME INFUSION SERVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
TABLE 165. AMERICAS HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 166. AMERICAS HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2025-2032 (USD MILLION)
TABLE 167. AMERICAS HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 168. AMERICAS HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
TABLE 169. AMERICAS HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 170. AMERICAS HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
TABLE 171. AMERICAS HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 172. AMERICAS HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
TABLE 173. AMERICAS HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 174. AMERICAS HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2025-2032 (USD MILLION)
TABLE 175. AMERICAS HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, 2018-2024 (USD MILLION)
TABLE 176. AMERICAS HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, 2025-2032 (USD MILLION)
TABLE 177. AMERICAS HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 178. AMERICAS HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, 2025-2032 (USD MILLION)
TABLE 179. AMERICAS HOME INFUSION SERVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 180. AMERICAS HOME INFUSION SERVICES MARKET SIZE, BY PAIN MANAGEMENT, 2025-2032 (USD MILLION)
TABLE 181. AMERICAS HOME INFUSION SERVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2024 (USD MILLION)
TABLE 182. AMERICAS HOME INFUSION SERVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2025-2032 (USD MILLION)
TABLE 183. NORTH AMERICA HOME INFUSION SERVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 184. NORTH AMERICA HOME INFUSION SERVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
TABLE 185. NORTH AMERICA HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 186. NORTH AMERICA HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2025-2032 (USD MILLION)
TABLE 187. NORTH AMERICA HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 188. NORTH AMERICA HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
TABLE 189. NORTH AMERICA HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 190. NORTH AMERICA HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
TABLE 191. NORTH AMERICA HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 192. NORTH AMERICA HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
TABLE 193. NORTH AMERICA HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 194. NORTH AMERICA HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2025-2032 (USD MILLION)
TABLE 195. NORTH AMERICA HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, 2018-2024 (USD MILLION)
TABLE 196. NORTH AMERICA HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, 2025-2032 (USD MILLION)
TABLE 197. NORTH AMERICA HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 198. NORTH AMERICA HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, 2025-2032 (USD MILLION)
TABLE 199. NORTH AMERICA HOME INFUSION SERVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 200. NORTH AMERICA HOME INFUSION SERVICES MARKET SIZE, BY PAIN MANAGEMENT, 2025-2032 (USD MILLION)
TABLE 201. NORTH AMERICA HOME INFUSION SERVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2024 (USD MILLION)
TABLE 202. NORTH AMERICA HOME INFUSION SERVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2025-2032 (USD MILLION)
TABLE 203. LATIN AMERICA HOME INFUSION SERVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 204. LATIN AMERICA HOME INFUSION SERVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
TABLE 205. LATIN AMERICA HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 206. LATIN AMERICA HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2025-2032 (USD MILLION)
TABLE 207. LATIN AMERICA HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 208. LATIN AMERICA HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
TABLE 209. LATIN AMERICA HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 210. LATIN AMERICA HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
TABLE 211. LATIN AMERICA HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 212. LATIN AMERICA HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
TABLE 213. LATIN AMERICA HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 214. LATIN AMERICA HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2025-2032 (USD MILLION)
TABLE 215. LATIN AMERICA HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, 2018-2024 (USD MILLION)
TABLE 216. LATIN AMERICA HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, 2025-2032 (USD MILLION)
TABLE 217. LATIN AMERICA HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 218. LATIN AMERICA HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, 2025-2032 (USD MILLION)
TABLE 219. LATIN AMERICA HOME INFUSION SERVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 220. LATIN AMERICA HOME INFUSION SERVICES MARKET SIZE, BY PAIN MANAGEMENT, 2025-2032 (USD MILLION)
TABLE 221. LATIN AMERICA HOME INFUSION SERVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2024 (USD MILLION)
TABLE 222. LATIN AMERICA HOME INFUSION SERVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2025-2032 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA HOME INFUSION SERVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA HOME INFUSION SERVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2025-2032 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
TABLE 229. EUROPE, MIDDLE EAST & AFRICA HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 230. EUROPE, MIDDLE EAST & AFRICA HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
TABLE 231. EUROPE, MIDDLE EAST & AFRICA HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 232. EUROPE, MIDDLE EAST & AFRICA HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
TABLE 233. EUROPE, MIDDLE EAST & AFRICA HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 234. EUROPE, MIDDLE EAST & AFRICA HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2025-2032 (USD MILLION)
TABLE 235. EUROPE, MIDDLE EAST & AFRICA HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, 2018-2024 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, 2025-2032 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, 2025-2032 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA HOME INFUSION SERVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA HOME INFUSION SERVICES MARKET SIZE, BY PAIN MANAGEMENT, 2025-2032 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA HOME INFUSION SERVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2024 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA HOME INFUSION SERVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2025-2032 (USD MILLION)
TABLE 243. EUROPE HOME INFUSION SERVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 244. EUROPE HOME INFUSION SERVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
TABLE 245. EUROPE HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 246. EUROPE HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2025-2032 (USD MILLION)
TABLE 247. EUROPE HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 248. EUROPE HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
TABLE 249. EUROPE HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 250. EUROPE HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
TABLE 251. EUROPE HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 252. EUROPE HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
TABLE 253. EUROPE HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 254. EUROPE HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2025-2032 (USD MILLION)
TABLE 255. EUROPE HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, 2018-2024 (USD MILLION)
TABLE 256. EUROPE HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, 2025-2032 (USD MILLION)
TABLE 257. EUROPE HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 258. EUROPE HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, 2025-2032 (USD MILLION)
TABLE 259. EUROPE HOME INFUSION SERVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 260. EUROPE HOME INFUSION SERVICES MARKET SIZE, BY PAIN MANAGEMENT, 2025-2032 (USD MILLION)
TABLE 261. EUROPE HOME INFUSION SERVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2024 (USD MILLION)
TABLE 262. EUROPE HOME INFUSION SERVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2025-2032 (USD MILLION)
TABLE 263. MIDDLE EAST HOME INFUSION SERVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 264. MIDDLE EAST HOME INFUSION SERVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
TABLE 265. MIDDLE EAST HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 266. MIDDLE EAST HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2025-2032 (USD MILLION)
TABLE 267. MIDDLE EAST HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 268. MIDDLE EAST HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
TABLE 269. MIDDLE EAST HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 270. MIDDLE EAST HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
TABLE 271. MIDDLE EAST HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 272. MIDDLE EAST HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
TABLE 273. MIDDLE EAST HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 274. MIDDLE EAST HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2025-2032 (USD MILLION)
TABLE 275. MIDDLE EAST HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, 2018-2024 (USD MILLION)
TABLE 276. MIDDLE EAST HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, 2025-2032 (USD MILLION)
TABLE 277. MIDDLE EAST HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 278. MIDDLE EAST HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, 2025-2032 (USD MILLION)
TABLE 279. MIDDLE EAST HOME INFUSION SERVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 280. MIDDLE EAST HOME INFUSION SERVICES MARKET SIZE, BY PAIN MANAGEMENT, 2025-2032 (USD MILLION)
TABLE 281. MIDDLE EAST HOME INFUSION SERVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2024 (USD MILLION)
TABLE 282. MIDDLE EAST HOME INFUSION SERVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2025-2032 (USD MILLION)
TABLE 283. AFRICA HOME INFUSION SERVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 284. AFRICA HOME INFUSION SERVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
TABLE 285. AFRICA HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 286. AFRICA HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2025-2032 (USD MILLION)
TABLE 287. AFRICA HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 288. AFRICA HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
TABLE 289. AFRICA HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 290. AFRICA HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
TABLE 291. AFRICA HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 292. AFRICA HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
TABLE 293. AFRICA HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 294. AFRICA HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2025-2032 (USD MILLION)
TABLE 295. AFRICA HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, 2018-2024 (USD MILLION)
TABLE 296. AFRICA HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, 2025-2032 (USD MILLION)
TABLE 297. AFRICA HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 298. AFRICA HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, 2025-2032 (USD MILLION)
TABLE 299. AFRICA HOME INFUSION SERVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 300. AFRICA HOME INFUSION SERVICES MARKET SIZE, BY PAIN MANAGEMENT, 2025-2032 (USD MILLION)
TABLE 301. AFRICA HOME INFUSION SERVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2024 (USD MILLION)
TABLE 302. AFRICA HOME INFUSION SERVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2025-2032 (USD MILLION)
TABLE 303. ASIA-PACIFIC HOME INFUSION SERVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 304. ASIA-PACIFIC HOME INFUSION SERVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
TABLE 305. ASIA-PACIFIC HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 306. ASIA-PACIFIC HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2025-2032 (USD MILLION)
TABLE 307. ASIA-PACIFIC HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 308. ASIA-PACIFIC HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
TABLE 309. ASIA-PACIFIC HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 310. ASIA-PACIFIC HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
TABLE 311. ASIA-PACIFIC HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 312. ASIA-PACIFIC HOME INFUSION SERVICES MARKET SIZE,